What Actually Ages a Face: The Assessment Behind Every Great Result

She sits down, pulls her cheek up with two fingers in the mirror, and says: "I hate this line."

And you already know — the line is not the problem. The line is the receipt. It's the last thing to show up and the last thing you should be treating directly.

This is the part of the job nobody puts on a course flyer. The injecting is the visible half. The invisible half — the twenty seconds where your eyes move across a face and quietly build a map of what's changed and in what order — is the half that decides whether the result looks filled or looks rested. That's the skill. Let's put words to it.

A face doesn't age in one place. It ages in four.

Facial aging isn't a single process — it's four different tissues changing on four different timelines, all at once. Every great assessment is really just this question asked four times: at which layer did this face lose what it lost?

Read them from the bottom up. That's the order they collapse in, and it's the order you should think in.

Layer 1: Bone — the foundation moves, and everything on top of it follows

Here's the part patients never expect: the skeleton itself remodels. It's not just soft tissue sliding downhill over a fixed frame — the frame changes shape.

The literature on the aging facial skeleton is consistent about where. The orbital aperture enlarges, particularly at the superomedial and inferolateral rims — with reported increases on the order of 15–20% by the seventh decade in predominantly Caucasian CT cohorts (East Asian series haven't consistently replicated this, which is worth remembering before you generalize across every patient in your chair). The midface retrudes: the pyriform aperture widens and maxillary height declines (reported in the range of roughly 8–15%, though a meaningful share of that is alveolar resorption tied to dentition rather than aging itself), which pulls back the very platform the medial cheek sits on. And the mandible loses height and length while the gonial angle opens — reported increases run from roughly 3° up past 10° depending on the cohort and dentition status — softening the jawline's definition from underneath.

There's a sex pattern often quoted, too: one recent review reports more pronounced orbital change in women and more mandibular remodeling in men, though other cohorts have found the strongest mandibular effects in postmenopausal women. Treat it as a tendency, not a rule.

What this means at the chair: when the tear trough deepens and the lateral brow drops on a patient who hasn't lost a pound, you're not looking at a filler deficiency. You're looking at a support deficiency. Treating the shadow without addressing the platform underneath it is how you end up with a heavy, puffy result that somehow makes the patient look more tired, not less.

Reading structure before treating surface — the assessment is the treatment plan

Layer 2: Fat — the deep pads deflate, the superficial ones slide

Facial fat isn't one blanket. It's a set of discrete compartments, superficial and deep, separated by septa and the extensions of the retaining ligaments — and they do not age the same way.

The pattern reported across the anatomy literature: deep compartments tend to atrophy, while superficial compartments tend to descend (and in some regions, appear relatively heavier). The consequential one is the deep medial cheek fat. As it deflates, the overlying superficial fat loses its scaffolding and shifts down and in.

That single mechanism explains an enormous amount of what your patients complain about — the deepening nasolabial fold, the flattening midface, the hollow under the tear trough. It's why the field talks about pseudoptosis: the tissue looks like it fell, but it mostly sank because what was holding it up went away.

What this means at the chair: the nasolabial fold is frequently a midface support finding, not a nasolabial finding. If your instinct with a deepening fold is to inject the fold, pause and ask what would happen if you restored the deep support instead. Very often you treat one area and three complaints improve — which is also, incidentally, the fastest way to become the injector people drive an hour to see.

Layer 3: Ligaments and septa — where the face is anchored is where it creases

The retaining ligaments tether skin, SMAS, and subcutaneous tissue down to muscle, bone, and fascia. They're the reason aging doesn't happen as a smooth slide — it happens in segments, with a crease at every anchor point.

In cadaveric biomechanical testing, the zygomatic ligament is the strongest of the group and the most resistant to failure. Combine that fixed anchor with volume loss and tissue descent above and below it, and you get the mid-cheek furrow — the obliquely oriented furrow running across the cheek lateral to the nasolabial fold that's a hallmark of midface aging.

The jawline is where the assumptions get interesting. It's tempting to blame jowls on a lax mandibular ligament — but recent cadaveric work suggests the mandibular ligament actually develops minimal laxity, and that jowling is driven mainly by descent of the cheek fat compartments (along with lengthening and laxity of the subcutaneous layer overlying the ligament) rather than by ligament failure. Worth knowing that the classical ligament-laxity model is still what most training teaches — this is a revision, not settled consensus. Marionette lines follow the same logic: differential volume loss plus descent, not a line that simply "appeared."

What this means at the chair: a crease at a known anchor point is a boundary, not a target. Treating boundaries directly is how faces start to look filled. Treating what's on either side of the boundary is how they start to look supported.

Layer 4: Skin — the layer no syringe fixes

Then there's the envelope. And this is where the honest conversation lives, because it's the layer patients most want you to fix with filler and the one filler addresses least.

The commonly cited rule of thumb is roughly 1% collagen loss per year from the mid-twenties onward — steady, quiet, cumulative. Then menopause changes the slope entirely: the foundational Brincat data reported that women lose about 30% of dermal collagen in the first five postmenopausal years, followed by roughly 2.1% per year over the subsequent decade and a half. (Fair disclosure: that was thigh-skin biopsy in a small 1987 cohort, so treat it as directional rather than a facial measurement.) Still — a patient two years past menopause is not on the same curve she was on at 40, and telling her so, kindly, is one of the most respected things you can do in a consult.

And the sun. In a study of 298 Caucasian women, sun exposure was estimated to account for roughly 80% of visible facial aging signs — driven almost entirely by pigmentation, wrinkles, and texture. Notably, in that same study sagging tracked with chronological age, not sun history. Which is the cleanest summary of this whole article: the shadows and the sag are structural. The tone, the texture, and the spots are largely sun.

What this means at the chair: if skin quality is the dominant finding and you treat it with volume, you will get a patient who is larger but not fresher — and she won't be able to tell you why she's disappointed. Naming the layer out loud ("this is a skin-quality finding, and here's what actually moves it") protects the result and the relationship.

The anatomy conversation is the trust conversation

The fifth question: what does the face do?

Four layers, and then one more variable that no static photo will ever show you: movement.

A face at rest is half the information. Static rhytids that persist at rest are a different problem from dynamic lines that only appear on animation. Compensation patterns matter too — the patient recruiting frontalis all day to hold a heavy brow up will read as "always surprised," and treating that frontalis without understanding why it's working is how you create the heaviness you were hired to fix.

Assess at rest. Assess in animation. Assess in the mirror with her, so she's watching her own face do the thing you're describing. That last one isn't a clinical step — it's a trust step, and it converts.

A repeatable read (the part you can use tomorrow)

Structured assessment frameworks exist precisely because "I just look at the face" doesn't scale and doesn't teach. Dr. Mauricio de Maio's MD Codes and the related MD ASA consultation tool formalize an idea worth borrowing regardless of what product you use: start from the message the face is sending (tired, sad, angry, saggy) rather than the line the patient is pointing at, then narrow down through facial thirds, to units, to subunits — leaving the individual lines and folds (what de Maio calls "distractions") for last. And sequence the treatment itself as foundation → contour → refinement.

Here's that idea compressed into something you can run in ninety seconds:

#	Step	The question you're answering
1	Listen	What is she asking for — and what is she actually feeling when she looks in the mirror?
2	Read the whole face	What message does this face send at rest? Which third is driving it?
3	Assign the layer	Bone, deep fat, ligament/boundary, or skin quality — which is dominant?
4	Watch it move	What's static, what's dynamic, and what's compensating?
5	Sequence it	Foundation first, contour second, refinement last — across visits if needed.

Notice what step 5 does: it turns a single appointment into a plan. Patients who understand they're on a sequence stop shopping for the cheapest syringe in town and start being your patients.

What to say in the room

Assessment only pays off if it survives translation. A few phrasings that carry the anatomy without a lecture:

"The line you're pointing at is the shadow. What's casting it is up here — so that's where I want to work first."

"We can chase this fold every four months, or we can rebuild the support above it and the fold gets quieter on its own."

"This one's a skin-quality finding. Filler won't touch it, and I'd rather tell you that than sell you something that doesn't work."

That last sentence has probably built more injector careers than any technique ever has.

Then write it down

Here's the unglamorous ending: the assessment you just performed is also the strongest thing in your chart. Documented facial assessment — the findings, the layer, the plan, the sequence, the why — is what demonstrates clinical reasoning if anyone ever reads that note back to you. It's also what makes your six-month follow-up brilliant instead of improvised, because future-you gets to see exactly what past-you was thinking.

We built ScribeFlow so that dictating that reasoning takes about as long as thinking it, and so the note comes out structured instead of scattered. That's the whole pitch, and we'll leave it there. The judgment is yours — we just want it captured before the next patient walks in.

FAQ

Should I assess the full face even when the patient came in for one area? Assess it, yes — and document it. Whether you treat full-face is a separate conversation involving budget, consent, and the patient's goals. But you can't sequence what you never assessed, and "she only asked about her lips" is a weak answer when the result doesn't hold.

Is it worth explaining anatomy to patients, or does it overwhelm them? Explain the mechanism, not the vocabulary. Patients don't need "deep medial cheek fat." They need "the support up here went away, and that's why this line showed up down there." One sentence, in the mirror, with her watching.

Does understanding bone remodeling change what I actually inject? Often it changes where and in what order more than what. Recognizing a support deficiency rather than a line deficiency is what moves you from filling folds to building faces — and it's exactly the judgment that stays with you no matter which products come and go.

Educational content for licensed professionals — not medical advice, training, or a substitute for hands-on anatomy education. Treatment decisions belong to you, your training, and your medical director. Facial anatomy varies; assess every patient individually.